Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to register for free online access

Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Fuchikami, K.
Right arrow Articles by Reinemer, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fuchikami, K.
Right arrow Articles by Reinemer, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Versatile High-Throughput Screen for Inhibitors of Lipid Kinase Activity: Development of an Immobilized Phospholipid Plate Assay for Phosphoinositide 3-Kinase {gamma}

Kinji Fuchikami

Asthma Research, Bayer Yakuhin Ltd., Research Center Kyoto, Japan

Hiroko Togame

Screening Technologies, Bayer Yakuhin Ltd., Research Center Kyoto, Japan

Atsuko Sagara

Screening Technologies, Bayer Yakuhin Ltd., Research Center Kyoto, Japan

Tomoko Satoh

Screening Technologies, Bayer Yakuhin Ltd., Research Center Kyoto, Japan

Florian Gantner

Asthma Research, Bayer Yakuhin Ltd., Research Center Kyoto, Japan

Kevin B. Bacon

Asthma Research, Bayer Yakuhin Ltd., Research Center Kyoto, Japan

Peter Reinemer

Screening Technologies, Bayer Yakuhin Ltd., Research Center Kyoto, Japan

The family of phosphoinositide 3-kinases (PI3K) regulates fundamental cellular responses such as proliferation, apoptosis, motility, and adhesion. In particular, the PI3K {gamma} isoform plays a critical role in the control of cell migration. Despite the attractiveness of PI3-kinases as drug targets, drug discovery efforts have been hampered by the lack of appropriate lipid kinase assay formats suitable for high-throughput screening. The authors report the development of a simple and robust 384-well plate assay that is based on33 P-phosphate transfer from radiolabeled [{gamma}33 P]ATP to phosphatidylinositol immobilized on MaxisorpTM plates. The established assay format for PI3K {gamma} was easily adapted to the automated screening platform and was successfully employed for high-throughput screening. Enzymatic and inhibition characteristics of recombinant human PI3K {gamma} determined with the plate assay are in very good agreement with previously reported values determined in other assay formats. Maximal catalytic activity of PI3K {gamma} was observed at pH 7.0. The apparent Km value for ATP using a 1:1 mixture of phosphatidylinositol and phosphatidylserine was determined to be 7.3µM (6.0-8.6 µM, 95% confidence interval [CI]). IC50 values for known PI3-kinase inhibitors were determined to be 1.45 nM (1.17-1.80 nM, 95% CI) for wortmannin and estimated from partial inhibition data to be 1400, 2830, and 21,400 nM for quercetin, LY294002, and staurosporine, respectively. This novel assay approach allows for screening of inhibitors of lipid kinases in high-throughput mode and thereby may facilitate the identification of novel inhibitory structures for drug development.

Journal of Biomolecular Screening, Vol. 7, No. 5, 441-450 (2002)
DOI: 10.1177/108705702237676
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J Biomol ScreenHome page
T. Lingaraj, J. Donovan, Z. Li, P. Li, A. Doucette, S. Harrison, J. A. Ecsedy, L. Dang, and W. Zhang
A High-Throughput Liposome Substrate Assay with Automated Lipid Extraction Process for PI 3-Kinase
J Biomol Screen, October 1, 2008; 13(9): 906 - 911.
[Abstract] [PDF]

Home page
 J Biomol ScreenHome page
T. A. Klink, K. M. Kleman-Leyer, A. Kopp, T. A. Westermeyer, and R. G. Lowery
Evaluating PI3 Kinase Isoforms Using TranscreenerTM ADP Assays
J Biomol Screen, July 1, 2008; 13(6): 476 - 485.
[Abstract] [PDF]

Home page
 J Biomol ScreenHome page
C. Stankewicz and F. H. Rininsland
A Robust Screen for Inhibitors and Enhancers of Phosphoinositide-3 Kinase (PI3K) Activities by Ratiometric Fluorescence Superquenching
J Biomol Screen, June 1, 2006; 11(4): 413 - 422.
[Abstract] [PDF]